Antidepressant Actions of Ketamine vs. Hydroxynorketamine. Biological Psychiatry, e65-e67.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• NMDAR inhibition-independent antidepressant actions of ketamine metabolites

  2016cited by this paper
• Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study.

  2016cited by this paper
• Ketamine and phencyclidine: the good, the bad and the unexpected

  2015cited by this paper
• Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression.

  2012influential reference
• Long-term depression in the CNS

  2010influential reference
• An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder

  2008cited by this paper
• Developing, Integrating and Delivering Successful Distributed Learning Environments For Your Students: Best Practices and Lessons Learned: The Good, the Bad and the Unexpected!

  2006cited by this paper
• Reconsolidation of memory after its reactivation.

  1997cited by this paper
• Effects of memantine and MK‐801 on NMDA‐induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices

  1996cited by this paper
• The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate

  1983cited by this paper
• Excitatory amino acids in synaptic transmission in the Schaffer collateral‐commissural pathway of the rat hippocampus.

  1983cited by this paper

• A Broadly Applicable Diels-Alder-Based Synthesis of Ketamine-Related Arylcyclohexylamines.

  2023cites this paper
• Comments to Drs. Bahji, Vazquez, and Zarate.

  2021cites this paper
• CYP 450 enzymes influence (R,S)-ketamine brain delivery and its antidepressant activity.

  2021cites this paper
• Sex Differences in the Behavioral, Molecular, and Structural Effects of Ketamine Treatment in Depression

  2021cites this paper
• (2R,6R)-Hydroxynorketamine, A Metabolite of Ketamine: The Antidepressant Actions and the Mechanisms

  2021cites this paper
• (R)-Ketamine: A New Rapid-Acting Antidepressant

  2021cites this paper
• Ketamine: Neuroprotective or Neurotoxic?

  2021cites this paper
• Family of Structurally Related Bioconjugates Yields Antibodies with Differential Selectivity against Ketamine and 6-Hydroxynorketamine.

  2021cites this paper
• (2S,6S)- and (2R,6R)-hydroxynorketamine inhibit the induction of NMDA receptor-dependent LTP at hippocampal CA1 synapses in mice

  2020cites this paper
• Encoding, Consolidation, and Renormalization in Depression: Synaptic Homeostasis, Plasticity, and Sleep Integrate Rapid Antidepressant Effects

  2020cites this paper
• Ketamine and nitrous oxide: The evolution of NMDA receptor antagonists as antidepressant agents.

  2020cites this paper
• Persistent memories of long-term potentiation and the N-methyl-d-aspartate receptor

  2019cites this paper
• Dendritic Spine Elimination: Molecular Mechanisms and Implications

  2019cites this paper
• Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine.

  2019cites this paper
• Ketamine metabolite (2R,6R)-hydroxynorketamine enhances aggression via periaqueductal gray glutamatergic transmission.

  2019cites this paper
• Evaluation of the Wistar-Kyoto Rat Model of Depression and the Role of Synaptic Plasticity in Depression and Antidepressant Response.

  2019cites this paper
• Rodent ketamine depression-related research: finding patterns in a literature of variability.

  2019cites this paper
• Lack of metabolism in (R)-ketamine’s antidepressant actions in a chronic social defeat stress model

  2018cites this paper
• Alternatives to ketamine in depression: state-of-the-art and future perspectives

  2018cites this paper
• The role of glutamatergic modulation in the mechanism of action of ketamine, a prototype rapid-acting antidepressant drug

  2018cites this paper
• Putative rapid-acting antidepressant nitrous oxide (“laughing gas”) evokes rebound emergence of slow EEG oscillations during which TrkB signaling is induced

  2018cites this paper
• Hyperforin Potentiates Antidepressant-Like Activity of Lanicemine in Mice

  2018cites this paper
• Cortical Excitability and Activation of TrkB Signaling During Rebound Slow Oscillations Are Critical for Rapid Antidepressant Responses

  2018cites this paper
• Ketamine, but Not the NMDAR Antagonist Lanicemine, Increases Prefrontal Global Connectivity in Depressed Patients

  2018cites this paper
• Intravascular Ketamine Increases Theta-Burst but Not High Frequency Tetanus Induced LTP at CA3-CA1 Synapses Within Three Hours and Devoid of an Increase in Spine Density

  2018cites this paper
• Studying the synaptome: insights into ketamine action

  2018cites this paper
• Hydroxynorketamine: Implications for the NMDA Receptor Hypothesis of Ketamine’s Antidepressant Action

  2017influential citation
• Ketamine metabolites with antidepressant effects: Fast, economical, and eco‐friendly enantioselective separation based on supercritical‐fluid chromatography (SFC) and single quadrupole MS detection

  2017cites this paper
• BDNF at the Synapse: Why Location Matters

  2017cites this paper
• Backing into the future: pharmacological approaches to the management of resistant depression

  2017cites this paper
• Reply to: Antidepressant Actions of Ketamine Versus Hydroxynorketamine.

  2017cites this paper